The Baruch S. Blumberg Biosafety Committee (BIBC) is a group Committee responsible for reviewing and approving recombinant DNA research and research involving the use of biological substances, toxins and cytotoxic carcinogens. It also periodically reviews previously approved research projects for changes which would necessitate increasing or decreasing the Biological Safety Levels.
Specifically, the BIBC evaluates research projects that use recombinant DNA, agents that are infectious to humans, animals and plants, other potentially infectious materials such as select agents and biological toxins, human materials including blood, cells, unfixed human tissues and other body fluids, and xenotransplants.
The BIBC coordinates its application procedures with the Director of Scientific Facilities (DSF), and the PA Biotechnology Center Safety Committee (BCSC) in order to ensure that research personnel have adequate occupational health monitoring, training on safe work practices, exposure control emergencies and use of personal protective equipment (PPE). The BIBC also operates in accordance with standards and guidelines from the National Institutes of Health (NIH) and the Center for Disease Control and Prevention (CDC), as well as regulations established by the Occupational Safety and Health Administration (OSHA). It also conducts operations consistent with city, state, and institutional standards and regulations.
Meeting dates and times vary depending upon the number of protocols submitted for review. To obtain meeting dates and times, and copies of the minutes of the meetings, please contact the BioSafety Coordinator at 215.489.4943.